J Zidan I Dashkovsky C Stayerman W Basher C Cozacov A Hadary
10.1038/sj.bjc.6602738
Br J Cancer
2005 Sep 5;93(5):552-6.
CC BY
https://pubmed.ncbi.nlm.nih.gov/16106267/
Breast Neoplasms / genetics Carcinoma, Ductal, Breast / genetics Carcinoma, Lobular / genetics Neoplasm Metastasis / pathology Receptor, ErbB-2 / metabolism
Breast Neoplasms / genetics Carcinoma, Ductal, Breast / genetics Carcinoma, Lobular / genetics Neoplasm Metastasis / pathology Receptor, ErbB-2 / metabolism Case Reports Comparative Study Research Support, Non-U.S. Gov't Adult Aged Aged, 80 and over Breast Neoplasms / metabolism Breast Neoplasms / pathology Carcinoma, Ductal, Breast / metabolism Carcinoma, Ductal, Breast / pathology Carcinoma, Lobular / metabolism Carcinoma, Lobular / pathology Female Humans Immunoenzyme Techniques In Situ Hybridization, Fluorescence Male Middle Aged Neoplasm Staging Prognosis Receptor, ErbB-2
PMC2361603
16106267
Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease
2005